J1453 Fosaprepitant - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Fosaprepitant

Brand Name:

Emend

Strength:

150 mg

HCPCS:

J1453

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Antiemetic

Minor Drug Class:

Substance P/Neurokinin 1

Oral (Y/N):

No

FDA Approval Year:

2008

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2009

CMS Discontinuation Date:

Status:

In Use